Avalo Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Avalo Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025

Transcript

Q2 2025

Aug 7, 2025

Quarterly report10-Q

Earnings release8-K

Corporate Presentation

Jun 19, 2025

Slides

Q1 2025

May 12, 2025

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 11, 2025

Transcript

Corporate Presentation

Jan 11, 2025

Slides

2024

Q4 2024

Mar 19, 2025

Earnings release8-K

Annual report10-K

Q3 2024

Nov 6, 2024

Quarterly report10-Q

Corporate Presentation

Sep 9, 2024

Slides

Q2 2024

Aug 11, 2024

Earnings release8-K

Quarterly report10-Q

Q1 2024

May 12, 2024

Earnings release8-K

Quarterly report10-Q

2023

Q4 2023

Mar 28, 2024

Annual report10-K

Q3 2023

Nov 8, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 2, 2023

Earnings release8-K

Quarterly report10-Q

Q1 2023

May 3, 2023

Earnings release8-K

Quarterly report10-Q

2022

Q4 2022

Mar 28, 2023

Annual report10-K

Q3 2022

Nov 6, 2022

Earnings release8-K

Quarterly report10-Q

Q2 2022

Aug 3, 2022

Earnings release8-K

Quarterly report10-Q

Q1 2022

May 4, 2022

Earnings release8-K

Quarterly report10-Q

2021

Q4 2021

Mar 1, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 8, 2021

Earnings release8-K

Quarterly report10-Q

Q2 2021

Aug 1, 2021

Earnings release8-K

Quarterly report10-Q

Q1 2021

May 12, 2021

Earnings release8-K

Quarterly report10-Q